bluebird bio, Inc. (BLUE) is down 40.17 percent during Friday's trading, falling $2.83 to trade at $4.21 after announcing a definitive agreement to be acquired by Carlyle and SK Capital Partners.
The stock opened at $4.91 and has traded between $4.00 and $5.65 today. Volume has surged to 4.27 million shares, well above its average of 392,053. BLUE's 52-week range is $4.00 to $38.40.
The deal includes a leadership transition, with David Meek expected to become CEO upon closing.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.